FDA Drug Application (017813) for LIBRELEASE by VALEANT PHARM INTL

Back to FDA Applications sponsored by VALEANT PHARM INTL

Application Number017813
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage30MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLIBRELEASE
Active IngredientCHLORDIAZEPOXIDE



Back to FDA Applications sponsored by VALEANT PHARM INTL

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.